Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-01, Stock:PFE, The news for the past five days is as follows:
2018-09-24: NEWS1: Asian Markets Mostly Lower Amid Cautious Trade.NEWS2: Asian Markets Mostly Lower Amid Cautious Trade.NEWS3: Australian Market Edges Higher.NEWS4: Australian Market Edges Higher.NEWS5: Why JNJ Stock Rose ~2.4% Last Week.NEWS6: AP investigation: Drug prices going up despite Trump promise.NEWS7: A Look at Johnson & Johnson’s Valuation This Month.NEWS8: What Potential Do Analysts See for JNJ Stock?.NEWS9: AP investigation: Drug prices going up despite Trump promise.NEWS10: AP review: Drug prices keep going up despite Trump pressure.NEWS11: Resurgent Pfizer Stock Testing 19-Year Resistance.NEWS12: Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer.NEWS13: Today’s Research Reports on Stocks to Watch: Oragenics and Pfizer.NEWS14: Why Amarin Corporation Stock Is Exploding Higher Today.NEWS15: Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts.NEWS16: Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts.
2018-09-25: NEWS1: AKCA Up 33% In 2 Days, AGTC Awaits XLRS Data, EYPT On Watch.NEWS2: AKCA Up 33% In 2 Days, AGTC Awaits XLRS Data, EYPT On Watch.NEWS3: AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer.NEWS4: AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer.NEWS5: USMV, PFE, WM, ACN: Large Inflows Detected at ETF.NEWS6: USMV, PFE, WM, ACN: Large Inflows Detected at ETF.NEWS7: Allergan’s First Medical Aesthetics Innovation Center in China.NEWS8: AstraZeneca&apos;s Imfinzi Gets EU Nod for Early-Stage Lung Cancer.NEWS9: J&J Files for US Approval of Cancer Drug Erdafitinib.NEWS10: Factors of Influence in 2018, Key Indicators and Opportunity within Dorchester Minerals, Teladoc, Pfizer, Intercontinental Exchange, General Electric, and Prospect Capital — New Research Emphasizes Economic Growth.NEWS11: Asian Shares Mixed As Investors Weigh Risks.NEWS12: Asian Shares Mixed As Investors Weigh Risks.
2018-09-26: NEWS1: Pfizer’s Revenue and EPS Growth Rate.NEWS2: What’s Driving Pfizer’s Revenue?.NEWS3: Dow Movers: NKE, IBM.NEWS4: Dow Movers: NKE, IBM.NEWS5: A Look at Pfizer’s Performance So Far in September.NEWS6: Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018.NEWS7: Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018.NEWS8: Analyzing Perrigo’s Prescription Pharmaceuticals Business.NEWS9: A Closer Look at the Allergan–Bonti Deal.
2018-09-27: NEWS1: FDA Approves Pfizer's Lung Cancer Drug.NEWS2: FDA Approves Pfizer's Lung Cancer Drug.NEWS3: Pfizer's lung cancer drug gets FDA approval.NEWS4: Pfizer's lung cancer drug get FDA nod.NEWS5: U.S. FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer.NEWS6: Analysts Continue to Be Cautious about Teva Stock.NEWS7: MannKind Stock History.NEWS8: MannKind Stock History.NEWS9: Teva Stock Was Down ~5.6% Yesterday and ~10.9% in the Last Week.NEWS10: MannKind Stock History.NEWS11: Pfizer Declares 34-Cent Fourth-Quarter 2018 Dividend.NEWS12: Trade of the Day: Pfizer Stock Rallies Too Far, Too Fast.NEWS13: Trade of the Day: Pfizer Stock Rallies Too Far, Too Fast.NEWS14: Pfizer’s Earnings Quality and Dividend Performance.NEWS15: A Look at Pfizer’s Market Cap and Shareholding Pattern.NEWS16: Trade of the Day: Pfizer Stock Rallies Too Far, Too Fast.NEWS17: Assessing Pfizer’s Global Performance.
2018-09-28: NEWS1: Pfizer (PFE) Stock Moves 0.27%: What You Should Know.NEWS2: Pfizer (PFE) Stock Moves 0.27%: What You Should Know.NEWS3: Final Trades: T, DIS & more.NEWS4: Pfizer (PFE) Stock Moves 0.27%: What You Should Know.NEWS5: A Look at Sanofi’s Valuation Multiples in September.NEWS6: A Look at Eli Lilly’s Revenue Growth Rate.NEWS7: Pfizer's (PFE) Lung Cancer Drug Vizimpro Gets FDA Approval.NEWS8: Pfizer's (PFE) Lung Cancer Drug Vizimpro Gets FDA Approval.NEWS9: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS10: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS11: Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs.NEWS12: Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs.NEWS13: JNK, FTXH: Big ETF Outflows.NEWS14: JNK, FTXH: Big ETF Outflows.NEWS15: Stocks - Tesla Tumbles in Pre-market; Eli Lilly, BlackBerry Gain.NEWS16: Pfizer&apos;s (PFE) Lung Cancer Drug Vizimpro Gets FDA Approval.NEWS17: Comparing Pfizer Stock and Merck and Co. Stock.NEWS18: Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs.NEWS19: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS20: Comparing Pfizer Stock and Johnson & Johnson Stock.NEWS21: The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results.NEWS22: Here’s What Verastem’s Valuation Trend Indicates.NEWS23: QIAGEN Receives FDA Approval To Expand Use Of EGFR Test In Lung Cancer.NEWS24: QIAGEN Receives FDA Approval To Expand Use Of EGFR Test In Lung Cancer.

Answer: Rise